Your browser doesn't support javascript.
loading
EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming.
Adelaiye-Ogala, Remi; Budka, Justin; Damayanti, Nur P; Arrington, Justine; Ferris, Mary; Hsu, Chuan-Chih; Chintala, Sreenivasulu; Orillion, Ashley; Miles, Kiersten Marie; Shen, Li; Elbanna, May; Ciamporcero, Eric; Arisa, Sreevani; Pettazzoni, Piergiorgio; Draetta, Giulio F; Seshadri, Mukund; Hancock, Bradley; Radovich, Milan; Kota, Janaiah; Buck, Michael; Keilhack, Heike; McCarthy, Brian P; Persohn, Scott A; Territo, Paul R; Zang, Yong; Irudayaraj, Joseph; Tao, W Andy; Hollenhorst, Peter; Pili, Roberto.
Afiliação
  • Adelaiye-Ogala R; Department of Cancer Pathology and Prevention, University at Buffalo, Buffalo, New York.
  • Budka J; Department of Pharmacology and Toxicology, Indiana University, Indianapolis, Indiana.
  • Damayanti NP; Medical Sciences, Indiana University, Bloomington, Indiana.
  • Arrington J; Department of Biomedical Engineering, Purdue University, West Lafayette, Indiana.
  • Ferris M; Department of Biochemistry, Purdue University, West Lafayette, Indiana.
  • Hsu CC; Medical Sciences, Indiana University, Bloomington, Indiana.
  • Chintala S; Department of Biochemistry, Purdue University, West Lafayette, Indiana.
  • Orillion A; Department of Medicine, Indiana University, Indianapolis, Indiana.
  • Miles KM; Department of Pharmacology and Toxicology, Indiana University, Indianapolis, Indiana.
  • Shen L; Department of Cellular and Molecular Biology, University at Buffalo, Buffalo, New York.
  • Elbanna M; Center for Personalized Medicine, Roswell Park Cancer Institute, New York, New York.
  • Ciamporcero E; Department of Medicine, Roswell Park Cancer Institute, New York, New York.
  • Arisa S; Department of Pharmacology and Toxicology, Indiana University, Indianapolis, Indiana.
  • Pettazzoni P; Department of Medicine and Experimental Oncology, University of Turin, Turin, Italy.
  • Draetta GF; Department of Medicine, Indiana University, Indianapolis, Indiana.
  • Seshadri M; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hancock B; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Radovich M; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kota J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Buck M; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, New York, New York.
  • Keilhack H; Department of Surgery, Indiana University, Indianapolis, Indiana.
  • McCarthy BP; Department of Surgery, Indiana University, Indianapolis, Indiana.
  • Persohn SA; Department of Medical and Molecular Genetics, Indiana University, Indianapolis, Indiana.
  • Territo PR; Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, Buffalo, New York.
  • Zang Y; Epizyme Inc., Cambridge, Massachusetts.
  • Irudayaraj J; Department of Radiology and Imaging Sciences, Indiana University, Indianapolis, Indiana.
  • Tao WA; Department of Radiology and Imaging Sciences, Indiana University, Indianapolis, Indiana.
  • Hollenhorst P; Department of Radiology and Imaging Sciences, Indiana University, Indianapolis, Indiana.
  • Pili R; Department of Biostatistics, Indiana University, Indianapolis, Indiana.
Cancer Res ; 77(23): 6651-6666, 2017 12 01.
Article em En | MEDLINE | ID: mdl-28978636
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirróis / Carcinoma de Células Renais / Receptores Proteína Tirosina Quinases / Resistencia a Medicamentos Antineoplásicos / Proteína Potenciadora do Homólogo 2 de Zeste / Indóis / Neoplasias Renais / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirróis / Carcinoma de Células Renais / Receptores Proteína Tirosina Quinases / Resistencia a Medicamentos Antineoplásicos / Proteína Potenciadora do Homólogo 2 de Zeste / Indóis / Neoplasias Renais / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article